Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Healthtrust
QuintilesIMS
Citi
US Department of Justice
Johnson and Johnson
Covington
Fuji
Colorcon

Generated: February 21, 2018

DrugPatentWatch Database Preview

Virtus Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for VIRTUS PHARMS, and what generic and branded alternatives to VIRTUS PHARMS drugs are available?

VIRTUS PHARMS has seven approved drugs.



Summary for Virtus Pharms
US Patents:0
Tradenames:5
Ingredients:5
NDAs:7

Drugs and US Patents for Virtus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Virtus Pharms TRANEXAMIC ACID tranexamic acid INJECTABLE;INJECTION 202755-001 Feb 25, 2016 AP RX No No ➤ Sign Up ➤ Sign Up
Virtus Pharms PROMETRIUM progesterone CAPSULE;ORAL 019781-003 Oct 15, 1999 DISCN No No ➤ Sign Up ➤ Sign Up
Virtus Pharms LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 091291-002 Sep 12, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Virtus Pharms DAPSONE dapsone TABLET;ORAL 204074-001 May 10, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Virtus Pharms PROMETRIUM progesterone CAPSULE;ORAL 019781-002 Oct 15, 1999 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Virtus Pharms LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 091291-001 Sep 12, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Virtus Pharms DIAZEPAM diazepam TABLET;ORAL 070463-001 Feb 25, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Virtus Pharms DIAZEPAM diazepam TABLET;ORAL 070462-001 Feb 25, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Virtus Pharms DIAZEPAM diazepam TABLET;ORAL 070464-001 Feb 25, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Virtus Pharms DAPSONE dapsone TABLET;ORAL 204074-002 May 10, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Merck
Federal Trade Commission
Dow
Chinese Patent Office
Mallinckrodt
US Department of Justice
Cipla
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot